Agios Pharmaceuticals
AGIO
#5118
Rank
NZ$3.05 B
Marketcap
NZ$51.00
Share price
-2.56%
Change (1 day)
28.17%
Change (1 year)

EPS for Agios Pharmaceuticals (AGIO)

EPS in 2026 (TTM): NZ-$10.92

According to Agios Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$11.37. In 2021 the company made an earnings per share (EPS) of NZ$40.47 an increase over its 2020 EPS that were of NZ-$8.63.

EPS history for Agios Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$10.92
2021NZ$40.47-569.2%
2020NZ-$8.63-31%
2019NZ-$12.5013.93%
2018NZ-$10.97-10.53%
2017NZ-$12.2733.47%
2016NZ-$9.1961.34%
2015NZ-$5.7098.1%
2014NZ-$2.88-4.34%
2013NZ-$3.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
NZ$1.29-111.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.22-594.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.24-146.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
NZ-$2.86-74.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
NZ$6.30-155.36%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
NZ-$0.16-98.56%๐Ÿ‡บ๐Ÿ‡ธ USA